The Plasma Fractionation Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Plasma Fractionation Market?
The market size of the plasma fractionation sector has seen robust growth recently. The market is projected to surge from $31.42 billion in 2024 to $34.44 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 9.6%. The historical growth trend in the Plasma Fractionation Global Market Report 2024 market has seen a positive trajectory.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Plasma Fractionation Industry?
The Plasma Fractionation Global Market Report 2024 predicts the market size to reach $51.56 billion in 2029, growing at a compound annual growth rate (CAGR) of 10.6%.
Download Your Free Sample of the 2025 Plasma Fractionation Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Plasma Fractionation Market?
The key drivers in the plasma fractionation market are:
• Rising healthcare expenditure globally
• Growing applications of plasma-derived medicinal products
• Increasing investment in research and development
• Expansion of plasma fractionation facilities
Global Market Segmentation: Identifying Major Plasma Fractionation Industry Segments
The plasma fractionation market covered in this report is segmented –
1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes
Pre-order the 2025 Plasma Fractionation Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Plasma Fractionation Market?
The key trends in the electronic shelf label market are:
• New fractionation technologies development is a major emerging trend.
• There is a significant shift towards albumin and immunoglobulin therapies.
• The demand for specialty plasma products is on the rise.
• The marketplace is witnessing a focus shift on pathogen inactivation technologies and strategic collaborations and partnerships within the plasma industry.
Who Are the Top Competitors & Leading Players in the Plasma Fractionation Market?
Major companies in the plasma fractionation market are:
• Baxter International Inc.
• Bio Products Laboratory Limited
• Biotest AG
• CSL Limited
• Grifols S. A
• ADMA Biologics Inc.
• Green Cross Corporation
• Hualan Bioengineering Inc.
• Intas Pharmaceuticals Ltd.
• Japan Blood Products Organization
• Kedrion S. P. A.
• Kamada Ltd.
• LFB Biomedicaments S. A. S
• Octapharma AG
• Sanquin Plasma Products B. V.
• Shanghai Raas Blood Products Co. Ltd.
• Takeda Pharmaceutical Company
• Terumo BCT
• China Biologic Products Holdings Inc.
• China National Biotec Group
• Emergent BioSolutions Inc.
• Bharat Serum Vaccines Limited
• Plasma Therapeutics
• Prothya Biosolutions B. V.
• BioPharma Plasma LLC
• BioLife Plasma Services LP
Regional Dominance: Which Area Leads the Global Plasma Fractionation Market?
North America was the largest region in the plasma fractionation market in 2024
